Financial News
Headline News about Greenbrook Tms
![](https://cdn.benzinga.com/files/images/story/2023/08/16/dlocal_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Greenbrook TMS
August 14, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/31/image45.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Preview: Greenbrook TMS's Earnings
May 12, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/19/neuronetics-logo-rgb-purple-png.png?width=1200&height=800&fit=crop)
Neuronetics Inks Six-Year Exclusive Partnership With Greenbrook TMS
January 19, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/28/coursera_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/10/wall-street-bull.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/21/emergent_biosolutions_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/06/vbi_vaccines_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/17/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/03/tattooed_chef_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://investorplace.com/wp-content/uploads/2022/04/sofi_sofi1600.png)
![](https://investorplace.com/wp-content/uploads/2019/07/earnings-quarterly-earnings-pen.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/12/heron_therapeutics_-_logo_copy.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_287.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/27/image27.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/10/image_6.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/06/image20.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.